From Clinical guidelines — Diagnosis and treatment manual › Chapter 9: Genito-urinary diseases · Médecins Sans Frontières, Current online edition, 2026
Syndromic management and treatment protocols for sexually transmitted genital ulcers for clinicians in resource-limited settings.
- Issuer
- Médecins Sans Frontières
- Edition
- Current online edition, 2026
- Audience
- Clinicians working in resource-limited and humanitarian settings
- Evidence
- Expert consensus based on MSF field experience
- Reviewed
- 21 Oct 2026 · GMJ
What this guideline says
GMJ summary
This MSF clinical guideline provides syndromic management protocols for genital ulcers caused by sexually transmitted infections. It covers five principal aetiologies: syphilis (Treponema pallidum), chancroid (Haemophilus ducreyi), genital herpes (Herpes simplex), lymphogranuloma venereum (Chlamydia trachomatis), and donovanosis (Calymmatobacterium granulomatis).
The guideline emphasises that laboratory testing in the field is of limited value and recommends empirical treatment based on clinical presentation. A key principle is simultaneous treatment for both syphilis and chancroid, as both are frequent and cannot be reliably distinguished clinically. The guideline specifies detailed dosing regimens for each condition, alternative therapies for penicillin-allergic patients, and management of complications such as fluctuant lymph nodes.
Sexual partners receive the same treatment as the index patient regardless of symptoms, except in genital herpes where partners are treated only if symptomatic. Special considerations are provided for HIV-infected patients, pregnant women, and patients with recurrent episodes.
Key points
For clinicians — doses and thresholds as stated in the guideline
- For genital herpes first episode: aciclovir 400 mg PO 3 times daily for 7 days (within 5 days of symptom onset); for recurrence: same dose for 5 days (only effective if started during prodrome or within 24 hours)
- For early syphilis: benzathine benzylpenicillin 2.4 MIU IM single dose; for late latent syphilis: 2.4 MIU IM weekly for 3 weeks
- Alternative for penicillin allergy in syphilis: erythromycin 1 g PO twice daily for 14 days (early) or 30 days (late latent); or doxycycline 100 mg PO twice daily for same durations
- For chancroid: azithromycin 1 g PO single dose, or ceftriaxone 250 mg IM single dose, or erythromycin 1 g PO twice daily for 7 days
- Treat simultaneously for syphilis AND chancroid as both are frequent and cannot be correctly distinguished clinically
- For lymphogranuloma venereum: erythromycin 1 g PO twice daily for 14 days or doxycycline 100 mg PO twice daily for 14 days
- For donovanosis: continue treatment until complete disappearance of lesions (usually several weeks); azithromycin 1 g on day 1 then 500 mg daily, with addition of gentamicin 6 mg/kg IM daily in HIV-infected patients
- Sexual partners receive same treatment as patient (whether symptomatic or not), except genital herpes where partners treated only if symptomatic
Treatment protocols for genital ulcers by aetiology
Table extracted from the guideline
| Condition | First-line treatment | Alternative treatment | Duration/notes |
|---|---|---|---|
| Genital herpes (first episode) | Aciclovir 400 mg PO 3 times daily | — | 7 days (within 5 days of onset) |
| Genital herpes (recurrence) | Aciclovir 400 mg PO 3 times daily | — | 5 days (within 24 hours of onset) |
| Early syphilis | Benzathine benzylpenicillin 2.4 MIU IM | Erythromycin 1 g PO twice daily OR doxycycline 100 mg PO twice daily | Single dose / 14 days |
| Late latent syphilis | Benzathine benzylpenicillin 2.4 MIU IM weekly | Erythromycin 1 g PO twice daily OR doxycycline 100 mg PO twice daily | 3 weeks / 30 days |
| Chancroid | Azithromycin 1 g PO OR ceftriaxone 250 mg IM | Erythromycin 1 g PO twice daily | Single dose / 7 days |
| Lymphogranuloma venereum | Erythromycin 1 g PO twice daily | Doxycycline 100 mg PO twice daily | 14 days |
| Donovanosis | Azithromycin 1 g then 500 mg daily | Erythromycin 1 g PO twice daily OR doxycycline 100 mg PO twice daily | Until lesions disappear |
Source: Médecins Sans Frontières, Genital ulcers — MSF Clinical guidelines. Reproduced in summary form.
From the guideline
Verbatim
“Treat simultaneously for syphilis AND chancroid as both are frequent, and cannot be correctly distinguished on clinical grounds.”
Editor’s perspective
Why this matters for Georgia and the region
Prof. Giorgi Pkhakadze, MD, MPH, PhD
Editor-in-Chief, Georgian Medical Journal · Chair, Public Health Institute of Georgia · WHO consultant, health and migration
As someone who has worked extensively on STI control in the South Caucasus, I recognise the value of MSF's pragmatic syndromic approach for settings where laboratory confirmation is unavailable or delayed. The recommendation I would stress to Georgian clinicians is the simultaneous treatment for syphilis and chancroid—this reflects field realities where clinical differentiation is unreliable and untreated infection carries serious sequelae. However, implementation in Georgia requires a realistic caveat: benzathine benzylpenicillin, the first-line agent for syphilis, has faced global supply shortages, and national programmes must ensure consistent availability or have robust protocols for alternative regimens such as doxycycline or erythromycin. The guideline's emphasis on partner treatment aligns well with Georgian STI control policy, but health system capacity for partner notification and treatment remains a challenge in rural areas.
ORCID 0000-0001-7609-4515 · Perspective written for the GMJ Guidelines Library, 21 Oct 2026
Applicability
Georgia and the South Caucasus
This guideline is highly relevant for Georgia and the South Caucasus, where STI services often rely on syndromic management in primary care and remote settings. Georgian national STI programmes would need to consider local epidemiology—particularly the prevalence of specific aetiologies such as chancroid and donovanosis, which may differ from endemic regions mentioned in the guideline (East/West Africa, Southeast Asia, South America, Caribbean for lymphogranuloma venereum; South Africa, Papua New Guinea, India, Brazil, Caribbean for donovanosis). The emphasis on simultaneous treatment for syphilis and chancroid is practical for settings where laboratory confirmation is unavailable, though programmes should weigh this against antimicrobial stewardship concerns. Availability of benzathine benzylpenicillin and other first-line agents in Georgian essential medicines lists would need verification for implementation.
Questions this guideline answers
Quick answers
Why does the guideline recommend treating for both syphilis and chancroid simultaneously?
Both are frequent causes of genital ulcers and cannot be correctly distinguished on clinical grounds. Laboratory testing available in the field is of little value, so empirical dual treatment ensures adequate coverage.
When is aciclovir treatment for genital herpes recurrence effective?
Treatment is only effective if initiated during the prodromal phase or within 24 hours after the onset of symptoms. For recurrences, give aciclovir 400 mg PO 3 times daily for 5 days.
What should be done with fluctuant lymph nodes in chancroid or lymphogranuloma venereum?
Fluctuant lymph nodes may be aspirated through healthy skin as required, but do not incise and drain lymph nodes.
How long should donovanosis be treated?
Treatment should continue until the complete disappearance of the lesions, which usually takes several weeks. Stopping earlier risks recurrence. In HIV-infected patients, add gentamicin 6 mg/kg IM once daily to the chosen antibiotic regimen.
Related on GMJ
Interconnected resources
Dictionary of Public Health
GMJ News coverage
- Congenital Syphilis Surging in U.S.: A Physician's Urgent Call for ActionJul 2026
- Syphilis Among Gay and Bisexual Men Falls to Decade Low in EnglandJun 2026
- Novel Prime-and-Pull Vaccine Strategy Shows Promise Against Genital Herpes in Preclinical ModelsAug 2026
- Genital herpes cases rise in England despite overall STI declineJun 2026
Quality & accreditation
Same guideline
- Abnormal vaginal discharge — MSF Clinical guidelinesChapter 9: Genito-urinary diseases
- Urethral discharge — Clinical guidelines — Diagnosis and treatment manual — MSF Clinical guidelinesChapter 9: Genito-urinary diseases
- Genital infections — Clinical guidelines — MSF Clinical guidelinesChapter 9: Genito-urinary diseases
- Acute prostatitis — MSF Clinical guidelinesChapter 9: Genito-urinary diseases
- Acute pyelonephritis — MSF Clinical guidelinesChapter 9: Genito-urinary diseases
- Acute cystitis — MSF Clinical guidelinesChapter 9: Genito-urinary diseases
Other guidelines on this topic
- Abnormal vaginal discharge — MSF Clinical guidelines
- Summary of clinical presentations of tuberculosis — MSF Tuberculosis
- Urethral discharge — Clinical guidelines — Diagnosis and treatment manual — MSF Clinical guidelines
- Clinical presentation of tuberculosis in HIV-infected persons — MSF Tuberculosis
- Genital infections — Clinical guidelines — MSF Clinical guidelines
- Issuer
- Médecins Sans Frontières
- Guideline
- Clinical guidelines — Diagnosis and treatment manual
- Chapter
- Chapter 9: Genito-urinary diseases
- Type
- Clinical guideline (chapter)
- Edition
- Current online edition, 2026
- Status
- Current
- Published
- 2026-10-14
- Scope
- Syndromic management of genital ulcers caused by sexually transmitted infections
- Audience
- Clinicians working in resource-limited and humanitarian settings
- Evidence
- Expert consensus based on MSF field experience
- Record history
- Created 21 Oct 2026 · updated 21 Oct 2026 · next check Apr 2027
Médecins Sans Frontières. Genital ulcers. In: Clinical guidelines — Diagnosis and treatment manual. Chapter 9: Genito-urinary diseases [Internet]. Paris: MSF; 2026 [cited 2026 Oct 14]. Available from: https://medicalguidelines.msf.org/GMJ Guidelines Library records are original summaries written by the GMJ editorial team from the issuer’s published document and reviewed by a physician. They do not replace the full guideline. The document is the copyright of its issuer and is linked, not hosted. Spotted an error or a newer edition? Tell the Guidelines Desk.
Was this article helpful?

